📈 Business
·
Bloomberg
·
Kailera Therapeutics Files for US IPO to Fund Obesity Drugs
Kailera Therapeutics Inc. filed for a US initial public offering to help fund the development of its pipeline of obesity drugs. The company plans to use the funds for research and development of its products.
Kailera Therapeutics Inc. filed for a US initial public offering to help fund the development of its pipeline of obesity drugs.